Articles relating to COVID-19 including safety tips, research updates, and vaccine information.

Black Alabamians say state history plays a role in COVID-19 vaccine hesitancy

JACKSONVILLE, Ala. — Some African Americans may be hesitant about receiving a COIVD-19 vaccine, despite being disproportionately impacted by the virus. “I probably would take it, but right now I wouldn’t,” Tiffany Montgomery, a Jacksonville resident said. “I would be real hesitant to get in line right now.” Montgomery is like many other African Americans who…

Forma doses first patient in Phase I prostate cancer treatment trial

Clinical-stage biopharmaceutical company Forma Therapeutics has announced the dosing of the first patient in Phase I clinical trial of FT-7051 in men with metastatic castration-resistant prostate cancer (mCRPC). FT-7051 is a selective CREB-binding protein/E1A binding protein p300 (CBP/p300) inhibitor and co-activator of androgen receptor (AR). Prostate cancer is the second leading cause of cancer death…

Reify Health extends StudyTeam platform availability for clinical trials

Cloud-based solutions provider Reify Health has announced the availability of its patient enrollment performance management platform, StudyTeam, to clinical research sites in 100 countries across the globe. Last year, the company has expanded StudyTeam availability to 88 new countries. The latest milestone marks Reify Health’s investment in providing effective solutions to sites for the management…

Debiopharm begins Phase II trial of alisporivir against Covid-19 in France

Swiss biopharmaceutical firm Debiopharm has started the dosing of the first patient in a Phase II proof-of-concept clinical trial of its antiviral alisporivir (Debio 025) for treating hospitalised Covid-19 patients. The investigator-initiated, randomised, open-label study will be conducted by the AP-HP to evaluate the efficacy and safety of the cyclophilin inhibitor in treating early-stage Covid-19…